Category: hepatitis
Controlling hepatitis B in Sierra Leone
The leading cause of liver cancer worldwide is hepatitis B virus (HBV). Sierra Leone is thought to have a high percentage, at least 8%, of the population actively infected with HBV. Some studies report that in Sierra Leone, 6% to 11% of pregnant women have active HBV infection, which they can transmit to their babies Read More >
Posted on byCDC works with countries to identify children infected with hepatitis B virus and generate the evidence for hepatitis B vaccine birth dose introduction
Around the world, approximately 257 million people are infected with hepatitis B virus (HBV), and about 700,000 die every year as result of the long-term, chronic health threats from HBV, including liver disease and cancer. But, such suffering can be prevented with a vaccine! More tragic still, newborn babies infected at birth by their mothers, Read More >
Posted on byVaccination remains the most cost-effective strategy to get on track with hepatitis B elimination in resource-limited settings
![Midwife providing the 5-in-1 pentavalent vaccine (diphtheria-tetanus-pertussis [DTP], hepatitis B, and Haemophilus influenzae type b) during a routine vaccination session in Myanmar](https://blogs.cdc.gov/global/wp-content/uploads/sites/25/2017/07/midwife-providing-the-5-in-1-pentavalent-vaccine_1200-825x510.jpg)
Midwife providing the 5-in-1 pentavalent vaccine (diphtheria-tetanus-pertussis [DTP], hepatitis B, and Haemophilus influenzae type b) during a routine vaccination session in Myanmar In the 1990s, the Western Pacific Region had one of the highest prevalence rates of chronic hepatitis B infection in the world (>8%). As a result, in 2005, it was the first World Read More >
Posted on by